samarium-153

samarium–153

A radiopharmaceutical used to treat bone pain caused by cancer metastases.
References in periodicals archive ?
The patient eventually became hormone refractory on complete hormone ablation and was started on Samarium-153 with a brief duration of PSA response.
The two new radioisotopes are rhenium-186 and samarium-153, Atomic Energy Organization of Iran Deputy Director Mohammad Qannadi said.
Radiologist Edward Silberstein of the University of Cincinnati Medical Center has been investigating a host of radionuclides with a natural affinity for bone, including samarium-153, strontium-89, and rhenium-186.